Who owns ASLAN PHARMACEUTICALS LTD?
- Ticker: ASLN
- CUSIP Number: 04522r200
Tip: Access positions for across all investors
Analyze quarterly positions in Aslan Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Aslan Pharmaceuticals stock
Who bought or sold ASLAN PHARMACEUTICALS LTD this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 1.0M | $548k | 0% | Dec 2023 |
|
UBS Group | 625k | $326k | 100% | Dec 2023 |
|
Citadel Advisors | 489k | $255k | 174% | Dec 2023 |
|
Shay Capital | 400k | $209k | 100% | Dec 2023 |
|
Landscape Capital Management | 83k | $44k | 100% | Dec 2023 |
|
Millennium Management | 80k | $42k | 0% | Dec 2023 |
|
Waterfront Wealth | 41k | $21k | -17% | Dec 2023 |
|
Ikarian Capital | 35k | $6.5k | 0% | Dec 2023 |
|
Schonfeld Strategic Advisors | 28k | $15k | -70% | Dec 2023 |
|
Jane Street | 23k | $12k | 100% | Dec 2023 |
|
Onyx Bridge Wealth Group | 23k | $12k | 100% | Dec 2023 |
|
Capital Analysts | 2.0k | $999.925600 | 0% | Dec 2023 |
|
Rhumbline Advisers | 1.3k | $674.044600 | 0% | Dec 2023 |
|
Cutler | 1.2k | $0 | 20% | Mar 2024 |
|
Simplex Trading | 1.2k | $0 | 15% | Dec 2023 |
|
Who sold out of Aslan Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Tang Capital Management | Sep 2023 | 1.9M | $3.6M |
Citigroup | Sep 2023 | 58k | $107k |